LIVE

BRKR

Bruker Corporation

BRKR

NASDAQ·Healthcare·Medical - Devices·Mkt cap $9.2B

$61.64

▲ +1.65%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$28.53 - $64.54

P/E

—

Fwd P/E

25.37

Beta

1.30

Div Yield

0.33%

Avg Vol

2.4M

Shares Out

—

Mkt Cap

$9.2B

Price action

Price chart

Up 42.8% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

No bull reasons captured for this rating yet.

▼

Bear Case

2 risks

  • Average volatility.
  • Premium valuation to sector peers

Growth

Strong growth ahead

Value

Premium valuation to sector peers

Momentum

Hot

+65.0% over 3m

Quality

Strong

Mixed fundamentals

Dividend

Token

0.33% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 4, 2026

“
LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

Q1 26

$0.02

Next: Aug 4, 2026

Revenue trend · last 1Q

—

Q1 26

$823.4M

Margins · last 1Q

Profit

1.8%

View full earnings history →

Wall Street consensus

5 analysts · 40% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

40%

Hold

3

60%

Sell

0%

Median Price Target

$49.00

▼ -20.5% vs $61.64

Low $45.00
Median $49.00
High $70.00

Latest: Guggenheim · $70.00 · Jun 29, 2026

4 analysts covering

View full analyst page →

vs Industry

How BRKR stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.